<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font16 { font-size : 16; } .font17 { font-size : 17; } .font18 { font-size : 18; } .font19 { font-size : 19; } .font20 { font-size : 20; } .font23 { font-size : 23; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font14 { font-size : 14; } .font31 { font-size : 31; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font31">COVID- </span>
   <span class="font23">antibodies </span>
   <span class="font20">patients </span>
   <span class="font19">virus </span>
   <span class="font19">SARS-CoV- </span>
   <span class="font19">{border-style </span>
   <span class="font18">coronavirus </span>
   <span class="font18">px;} </span>
   <span class="font17">#ffffff;} </span>
   <span class="font17">convalescent </span>
   <span class="font16">antibody </span>
   <span class="font16">plasma </span>
   <span class="font15">vaccination </span>
   <span class="font15">viral </span>
   <span class="font15">severe </span>
   <span class="font15">therapy </span>
   <span class="font14">disease </span>
   <span class="font14">recovered </span>
   <span class="font14">COVID-. </span>
   <span class="font14">effective </span>
   <span class="font14">high </span>
   <span class="font14">immune </span>
   <span class="font14">potential </span>
   <span class="font13">BCG </span>
   <span class="font13">human </span>
   <span class="font13">patients. </span>
   <span class="font13">protein </span>
   <span class="font13">px; </span>
   <span class="font13">{font-family </span>
   <span class="font13">Accessed </span>
   <span class="font13">case </span>
   <span class="font13">children </span>
   <span class="font13">font-size </span>
   <span class="font13">inflammatory </span>
   <span class="font13">neutralizing </span>
   <span class="font13">protective </span>
   <span class="font13">studies </span>
   <span class="font13">virus-neutralizing </span>
   <span class="font12">Infect </span>
   <span class="font12">Korean </span>
   <span class="font12">acute </span>
   <span class="font12">countries </span>
   <span class="font12">course </span>
   <span class="font12">days </span>
   <span class="font12">double; </span>
   <span class="font12">effects </span>
   <span class="font12">immunoglobulin </span>
   <span class="font12">monoclonal </span>
   <span class="font12">rheumatic </span>
   <span class="font12">vaccine </span>
   <span class="font12">(COVID-) </span>
   <span class="font12">Chinese </span>
   <span class="font12">HIV- </span>
   <span class="font12">IVIg </span>
   <span class="font12">IgG </span>
   <span class="font12">antiviral </span>
   <span class="font12">border-color </span>
   <span class="font12">border-width </span>
   <span class="font12">cases </span>
   <span class="font12">cells </span>
   <span class="font12">clinical </span>
   <span class="font12">demonstrated </span>
   <span class="font12">early </span>
   <span class="font12">individuals </span>
   <span class="font12">measles </span>
   <span class="font12">multiple </span>
   <span class="font12">required </span>
   <span class="font12">respiratory </span>
   <span class="font12">response </span>
   <span class="font12">responses </span>
   <span class="font12">risk </span>
   <span class="font12">series </span>
   <span class="font12">serum </span>
   <span class="font12">solid; </span>
   <span class="font12">spike </span>
   <span class="font12">study </span>
   <span class="font12">subjects </span>
   <span class="font12">syndrome </span>
   <span class="font12">treatment </span>
   <span class="font12">use </span>
   <span class="font12">vaccinated </span>
   <span class="font12">{font-style </span>
   <span class="font12">{font-weight </span>
   <span class="font11">AY, </span>
   <span class="font11">Dis </span>
   <span class="font11">Gasparyan </span>
   <span class="font11">Immunol </span>
   <span class="font11">Med </span>
   <span class="font11">SARS-CoV-. </span>
   <span class="font11">Zimba </span>
   <span class="font11">antibodies. </span>
   <span class="font11">autoimmune </span>
   <span class="font11">based </span>
   <span class="font11">blocking </span>
   <span class="font11">bold </span>
   <span class="font11">courier; </span>
   <span class="font11">cross-reactivity </span>
   <span class="font11">em; </span>
   <span class="font11">high-risk </span>
   <span class="font11">host </span>
   <span class="font11">immunosuppressive </span>
   <span class="font11">initial </span>
   <span class="font11">interaction </span>
   <span class="font11">lung </span>
   <span class="font11">mAbs </span>
   <span class="font11">mortality </span>
   <span class="font11">nonspecific </span>
   <span class="font11">novel </span>
   <span class="font11">pandemic </span>
   <span class="font11">particularly </span>
   <span class="font11">production </span>
   <span class="font11">proteins </span>
   <span class="font11">pt;} </span>
   <span class="font11">related </span>
   <span class="font11">revealed </span>
   <span class="font11">spread </span>
   <span class="font11">strategies </span>
  </p>
 </body>
</html>
